Nuvation Bio (NUVB) Change in Account Payables (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Change in Account Payables of $13.0 million for Q1 2026, up 209.29% year-over-year from $4.2 million in Q1 2025, and up 320.3% quarter-over-quarter from -$5.9 million in Q4 2025.
Powered by 
Analysis
Nuvation Bio (NUVB) Change in Account Payables (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Change in Account Payables for 7 consecutive years, with $13.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 209.29% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $11.9 million (up 415.51% YoY), while the FY2025 annual figure was $3.1 million, up 289.3% from the prior year.
- Change in Account Payables climbed to $13.0 million in Q1 2026 per NUVB's latest filing, from -$5.9 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $13.0 million in Q1 2026 and bottomed at -$9.7 million in Q3 2022.
- Historically, Change in Account Payables has averaged $748058.8 across 5 years, with a median of -$164000.0 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 3614.22% in 2024 and fell as far as 3578.05% in 2024.
- Nuvation Bio's Change in Account Payables stood at -$856000.0 in 2022, then surged by 80.84% to -$164000.0 in 2023, then slumped by 3578.05% to -$6.0 million in 2024, then advanced by 2.5% to -$5.9 million in 2025, then jumped by 320.3% to $13.0 million in 2026.
- Business Quant data shows NUVB's Change in Account Payables at $13.0 million in Q1 2026, -$5.9 million in Q4 2025, and -$7.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.38 Bn | 2.38 Bn | 30.78 Mn | -9.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.85 Mn |
| Mar 31, 2026 | 12.96 Mn |
| Dec 31, 2025 | -5.88 Mn |
| Sep 30, 2025 | -7.06 Mn |
| Jun 30, 2025 | 11.88 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | -6.03 Mn |
| Sep 30, 2024 | 7.17 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | 227,000.00 |
| Dec 31, 2023 | -164,000.00 |
| Sep 30, 2023 | -204,000.00 |
| Jun 30, 2023 | -368,000.00 |
| Mar 31, 2023 | 806,000.00 |
| Dec 31, 2022 | -856,000.00 |
| Sep 30, 2022 | -9.73 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 636,000.00 |